Krebs von den Lungen-6
May aid in the evaluation of lung inflammation or injury in various types of interstitial lung disease (ILD).
New York DOH Approval Status
Serum separator tube (SST) or plain red
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 1.5 mL serum to ARUP standard transport tube. (Min: 0.5 mL)
Hemolyzed, hyperlipemic, icteric, heat-treated, or contaminated.
Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 month
Krebs von den Lungen-6 (KL-6) is an indicator of lung inflammation or damage. Elevated levels are associated with various types of interstitial lung diseases (ILD).
Abnormal KL-6 results should be interpreted in the appropriate clinical context. A negative result does not rule out ILD.
Laboratory Developed Test (LDT)
Samples with results greater than 10,000 U/mL will be diluted to the maximum reportable range (>40,000 U/mL).
|Component Test Code*||Component Chart Name||LOINC|
|3001867||Krebs von den Lungen-6||93369-7|
- interstitial lung disease
- KL 6
- Lung inflammation
- Lung Injury